Jörn Aldag is a German businessperson who founded G7 Therapeutics AG and who has been at the helm of 7 different companies. Currently, Mr. Aldag occupies the position of Chairman for GeneSpire Srl and Chief Executive Officer & Director at HOOKIPA Pharma, Inc., Chief Executive Officer at Hookipa Biotech AG (a subsidiary of HOOKIPA Pharma, Inc.). Jörn Aldag is also on the board of DESERTEC Foundation and Idorsia Ltd.
In the past he held the position of Chairman of Molecular Partners AG, President & Chief Executive Officer of Evotec SE, Chief Executive Officer for uniQure NV and Chief Executive Officer of Amsterdam Molecular Therapeutics (AMT) Holding NV (a subsidiary of uniQure NV), Finance Director & Vice President at MAN Gutehoffnungshutte AG and Director-Business Development at Treuhandanstalt.
He received an undergraduate degree from Harvard Business School and an undergraduate degree from European Business School Group.